Glutamate promotes secretion of MMP-2 and enhances invasion of glioma cells
Ke-jun Liu, Yongjian Lu, Zhiqun Min, Chun Li
Abstract
Ke-jun Liu, Yongjian Lu, Zhiqun Min, Chun Li
Abstract
Objective To investigate the mechanism of invasion of glioma evoked by glutamate.Methods Glioma cell line U251 was cultured in vitro; cell invasion of U251 was detected by Matrigel Transwell method 24 h after 100 μmol/L glutamate treatment; MMP-2 and MMP-9 secretions were detected by gelatin zymography assay 2,4,8 and 12 h afte glutamate treatment; the protein expression of extracellular matrix metalloproteinase inducer (EMMPRIN) was detected by Western blotting 3,6 and 9 h after glutamate treatment. Results Matrigel Transwell method indicated that the cells crossing the cytomembrane of U251 in the glutamate treatment group (37.44±2.31) were significantly increased as compared with those in the control group (25.89±3.00, P<0.05); MMP-2 secretion in the glutamate treatment group 8 and 12 h afte glutamate treatment was obviously increased as compared with that in the control group (P<0.05); while Western blotting indicated that no significant differences on the EMMPRIN level were noted between time points of 3, 6 and 9 h after glutamate treatment. Conclusion Glutamate promotes the secretion of MMP-2 in glioma cell line U251 to enhance the invasion of glioma cells; MMP-9 and EMMPRIN are not involved in the process of glutamate promoting the invading of U251. Key words: Glioma; Glutamate; Invasiveness; MMP-2
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the mechanism of invasion of glioma evoked by glutamate.Methods Glioma cell line U251 was cultured in vitro; cell invasion of U251 was detected by Matrigel Transwell method 24 h after 100 μmol/L glutamate treatment; MMP-2 and MMP-9 secretions were detected by gelatin zymography assay 2,4,8 and 12 h afte glutamate treatment; the protein expression of extracellular matrix metalloproteinase inducer (EMMPRIN) was detected by Western blotting 3,6 and 9 h after glutamate treatment. Results Matrigel Transwell method indicated that the cells crossing the cytomembrane of U251 in the glutamate treatment group (37.44±2.31) were significantly increased as compared with those in the control group (25.89±3.00, P<0.05); MMP-2 secretion in the glutamate treatment group 8 and 12 h afte glutamate treatment was obviously increased as compared with that in the control group (P<0.05); while Western blotting indicated that no significant differences on the EMMPRIN level were noted between time points of 3, 6 and 9 h after glutamate treatment. Conclusion Glutamate promotes the secretion of MMP-2 in glioma cell line U251 to enhance the invasion of glioma cells; MMP-9 and EMMPRIN are not involved in the process of glutamate promoting the invading of U251. Key words: Glioma; Glutamate; Invasiveness; MMP-2
Key concepts: Matrigel, Glutamate receptor, Glioma, Secretion, Blot, Matrix metalloproteinase, Chemistry, Cell culture